IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Blood glucose sensor and transmitter ...
The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...
For the first time, the US Food and Drug Administration has approved the use of a continuous glucose monitoring (CGM) system to replace finger-stick testing for determining insulin doses. The decision ...
ORLANDO — In a head-to-head trial comparing three currently available continuous glucose monitors (CGMs) for real-world use in diabetes, the newly approved implantable glucose monitor Eversense ...
SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today the U.S. Centers for Medicare & Medicaid Services (CMS) is ...
Dexcom is also consistently rated the #1 CGM brand in independent patient surveys 5. In addition to integration with the t:slim X2 Pump, dynamic glucose data from the Dexcom G5 Mobile CGM can be ...
Yesterday Dexcom got the nod from the FDA to market their Dexcom G6, an integrated continuous glucose monitoring system (iCGM), making it the first interoperable CGM to get the designation. “We are a ...
Tandem Diabetes Care, Dexcom and TypeZero Technologies are joining together to undertake a new clinical trial to investigate the use of an artificial pancreas system. The project will use Tandem’s ...
President and CEO Kevin Sayer said the company will file for Medicare coverage of the G6, while it continues to work out an issue that prevents beneficiaries from using a feature that lets data be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback